|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0025248,
umls-concept:C0041217,
umls-concept:C0185117,
umls-concept:C0205145,
umls-concept:C0205419,
umls-concept:C0205681,
umls-concept:C0332183,
umls-concept:C1517945,
umls-concept:C1533691,
umls-concept:C2911684
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-1-22
|
|
pubmed:abstractText |
African trypanosomes undergo antigenic variation of their variant surface glycoprotein (VSG) coat to avoid being killed by their mammalian hosts. The active VSG gene is located in one of many telomeric expression sites. Replacement of the VSG gene in the active site or switching between expression sites can give rise to a new VSG coat. To study Trypanosoma brucei VSG expression site inactivation rather than VSG gene switching, it is useful to have an in vitro negative-selection system independent of the VSG. We have achieved this aim by using a viral thymidine kinase (TK) gene. Following integration of the TK gene downstream of the 221a VSG expression site promoter, transformant cell lines became sensitive to the nucleoside analog 1-(2-deoxy-2-fluoro-8-D-arabinofuranosyl)-5-iodouracil. These TK trypanosomes were able to revert to resistance at a rate approaching 10(-5) per cell per generation. The majority of revertants expressed a new VSG gene even though there had been no selection against the VSG itself. Analysis of these switched variants showed that some had shut down TK expression via an in situ expression site switch. However, most variants had the complete 221 expression site deleted and another VSG expression site activated. We speculate that a new VSG expression site cannot switch on without inactivation of the old site.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-15275073,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-1697265,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-2225075,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-2233733,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-2259625,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-2614608,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-2842674,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-2861910,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-2988791,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-3003586,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-3009443,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-4761771,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-6086319,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-6202420,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-6292859,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-6311429,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-6488319,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-6692467,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-7585957,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-7585958,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-7637690,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-8617348,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-8657559,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-8668178,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-8854399,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-8885223,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-8920008,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-8967896,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-9001237,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-9084039,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9418867-9200123
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0270-7306
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
198-205
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Frequent loss of the active site during variant surface glycoprotein expression site switching in vitro in Trypanosoma brucei.
|
|
pubmed:affiliation |
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
